Ontology highlight
ABSTRACT: Objective
To assess the benefits and harms of different types and doses of anticoagulant drugs for the prevention of venous thromboembolism in patients who are acutely ill and admitted to hospital.Design
Systematic review and network meta-analysis.Data sources
Cochrane CENTRAL, PubMed/Medline, Embase, Web of Science, clinical trial registries, and national health authority databases. The search was last updated on 16 November 2021.Eligibility criteria for selecting studies
Published and unpublished randomised controlled trials that evaluated low or intermediate dose low-molecular-weight heparin, low or intermediate dose unfractionated heparin, direct oral anticoagulants, pentasaccharides, placebo, or no intervention for the prevention of venous thromboemboli
SUBMITTER: Eck RJ
PROVIDER: S-EPMC9251634 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature